Trexquant Investment LP Makes New $3.82 Million Investment in Sotera Health (NASDAQ:SHC)

Trexquant Investment LP bought a new stake in shares of Sotera Health (NASDAQ:SHC) in the 4th quarter, according to its most recent filing with the SEC. The institutional investor bought 279,211 shares of the company’s stock, valued at approximately $3,820,000. Trexquant Investment LP owned about 0.10% of Sotera Health at the end of the most recent quarter.

A number of other hedge funds have also made changes to their positions in SHC. Geode Capital Management LLC lifted its position in shares of Sotera Health by 0.9% during the fourth quarter. Geode Capital Management LLC now owns 2,780,445 shares of the company’s stock worth $38,048,000 after purchasing an additional 25,054 shares during the last quarter. Alliancebernstein L.P. lifted its holdings in Sotera Health by 2.2% during the 4th quarter. Alliancebernstein L.P. now owns 209,823 shares of the company’s stock worth $2,870,000 after buying an additional 4,560 shares during the last quarter. Pictet Asset Management Holding SA grew its position in shares of Sotera Health by 29.1% in the 4th quarter. Pictet Asset Management Holding SA now owns 21,593 shares of the company’s stock worth $295,000 after acquiring an additional 4,871 shares in the last quarter. Norges Bank bought a new stake in shares of Sotera Health in the 4th quarter valued at approximately $12,764,000. Finally, JPMorgan Chase & Co. raised its position in shares of Sotera Health by 3.1% during the 4th quarter. JPMorgan Chase & Co. now owns 255,341 shares of the company’s stock valued at $3,493,000 after acquiring an additional 7,594 shares in the last quarter. Institutional investors and hedge funds own 91.03% of the company’s stock.

Wall Street Analyst Weigh In

Separately, Barclays lowered their target price on shares of Sotera Health from $17.00 to $16.00 and set an “overweight” rating for the company in a research note on Friday, February 28th. Two research analysts have rated the stock with a hold rating and three have given a buy rating to the company. According to MarketBeat.com, Sotera Health has an average rating of “Moderate Buy” and an average price target of $16.00.

Sotera Health Trading Down 3.6 %

Shares of NASDAQ SHC opened at $10.34 on Monday. Sotera Health has a 12-month low of $10.05 and a 12-month high of $17.08. The company has a market cap of $2.93 billion, a price-to-earnings ratio of 41.36 and a beta of 1.88. The company has a current ratio of 2.88, a quick ratio of 2.61 and a debt-to-equity ratio of 4.91. The stock’s 50 day simple moving average is $12.61 and its 200 day simple moving average is $13.78.

Sotera Health Profile

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.